Compare · ALMR vs AVTR
ALMR vs AVTR
Side-by-side comparison of Alamar Biosciences Inc. (ALMR) and Avantor Inc. (AVTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALMR and AVTR operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- AVTR is the larger of the two at $10.88B, about 5.7x ALMR ($1.90B).
- Over the past year, ALMR is up 14.3% and AVTR is up 8.2% - ALMR leads by 6.1 points.
- ALMR has been more active in the news (6 items in the past 4 weeks vs 1 for AVTR).
- AVTR has more recent analyst coverage (25 ratings vs 5 for ALMR).
- Company
- Alamar Biosciences Inc.
- Avantor Inc.
- Price
- $25.36-7.16%
- $16.41+1.96%
- Market cap
- $1.90B
- $10.88B
- 1M return
- -20.87%
- +3.53%
- 1Y return
- +14.26%
- +8.17%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2026
- 2019
- News (4w)
- 6
- 1
- Recent ratings
- 5
- 25
Avantor Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Latest ALMR
- SEC Form 144 filed by Alamar Biosciences Inc.
- SEC Form 144 filed by Alamar Biosciences Inc.
- SEC Form 144 filed by Alamar Biosciences Inc.
- SEC Form 144 filed by Alamar Biosciences Inc.
- Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
- Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
- Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
- General Counsel Brottem John L. was granted 29,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Brottem John L.
- Director Ragusa Robert P was granted 5,686 shares (SEC Form 4)
Latest AVTR
- Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
- EVP and CFO Garner Todd W was granted 49,688 shares (SEC Form 4)
- SEC Form 3 filed by new insider Garner Todd W
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Avantor appoints new Chief Financial Officer
- UBS initiated coverage on Avantor with a new price target
- Amendment: Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- President and CEO Ligner Emmanuel covered exercise/tax liability with 29,803 shares, decreasing direct ownership by 4% to 737,334 units (SEC Form 4) to satisfy withholding obligation
- EVP, Chief HR Officer Hankamer Brittany covered exercise/tax liability with 181 shares, decreasing direct ownership by 0.07% to 248,864 units (SEC Form 4) (withholding tax)